UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004506
Receipt number R000005380
Scientific Title Study for severity and treatment methods in peripheral lymphedema by evaluation of lymph function
Date of disclosure of the study information 2010/11/06
Last modified on 2020/01/21 12:58:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for severity and treatment methods in peripheral lymphedema by evaluation of lymph function

Acronym

Study for severity and treatment methods in peripheral lymphedema by evaluation of lymph function

Scientific Title

Study for severity and treatment methods in peripheral lymphedema by evaluation of lymph function

Scientific Title:Acronym

Study for severity and treatment methods in peripheral lymphedema by evaluation of lymph function

Region

Japan


Condition

Condition

lymphedema

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study for severity and new methods of peripheral lymphedema

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Physiological evaluation of edema
Functional evaluation of lymph

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Period of 5 years
lymphoscintigraphy, fluorescence lymphography and, skin hardness measurement 1 or 2 times a year and physical examination 3-4 times a year

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Secondary and primary lymphedema

Key exclusion criteria

Other diseases with edema

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Maegawa Jiro

Organization

Yokohama City University Hospital

Division name

Plastic and Reconstructive Surgery

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004

TEL

045-787-2800

Email

maegawaj@med.yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Maegawa Jiro

Organization

Yokohama City University Hospital

Division name

Plastic and Reconstructive Surgery

Zip code


Address

Fukuura3-9, Kanazawa-ku, Yokohama city, Kanagawa-ken

TEL

045-787-2800

Homepage URL


Email

maegawaj@med.yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University Hospital

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 09 Month 02 Day

Date of IRB

2010 Year 09 Month 01 Day

Anticipated trial start date

2010 Year 09 Month 01 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 11 Month 05 Day

Last modified on

2020 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005380


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name